Sarcopenia is a risk factor for adverse outcome in critically ill patients. Sarcopeniamight be estimated from muscle surface measure on tomodensitometry.The purpose of the study is to identify if muscle surfaces measured on thoracictomodensitometry are associated with mortality in patients with acute respiratorydistress syndrome due to SARS-Cov-2.
Not Provided
Other: Data collection
Demographic data:
Age, Sex, weight, height, main history and treatments.
- Biological data: CRP, PCT, albumin, pre-albumin
Other: analysis of thoracic scans
muscle area calculated on the T7 and T12 thoracic slices
Inclusion Criteria:
- patients hospitalized in intensive care for SARS-Cov-2 infection since january 2020
- Thoracic TDM within the 30 day preceding ICU admission and up to 24 hours after ICU
admission
Exclusion Criteria:
- Pregnancy
- Neuromuscular disease
Not Provided
Maxime NGUYEN
380293528 - +33
maxime.nguyen-soenen@chu-dijon.fr
Not Provided